346 related articles for article (PubMed ID: 20334678)
1. PPARgamma gene C161T substitution alters lipid profile in Chinese patients with coronary artery disease and type 2 diabetes mellitus.
Wan J; Xiong S; Chao S; Xiao J; Ma Y; Wang J; Roy S
Cardiovasc Diabetol; 2010 Mar; 9():13. PubMed ID: 20334678
[TBL] [Abstract][Full Text] [Related]
2. Effect of the peroxisome proliferator-activated receptor-gamma C161T polymorphism on lipid profile in Brazilian patients with Type 2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scallissi N; Speranza AC; Gomes S; Hirata MH
J Endocrinol Invest; 2005 Feb; 28(2):129-36. PubMed ID: 15887858
[TBL] [Abstract][Full Text] [Related]
3. Effect of the PPARγ C161T gene variant on serum lipids in ischemic stroke patients with and without type 2 diabetes mellitus.
Chehaibi K; Nouira S; Mahdouani K; Hamdi S; Rouis M; Slimane MN
J Mol Neurosci; 2014 Dec; 54(4):730-8. PubMed ID: 24841086
[TBL] [Abstract][Full Text] [Related]
4. PPARgamma gene C161T substitution is associated with reduced risk of coronary artery disease and decreased proinflammatory cytokine expression.
Liu Y; Yuan Z; Liu Y; Zhang J; Yin P; Wang D; Wang Y; Kishimoto C; Ma A
Am Heart J; 2007 Oct; 154(4):718-24. PubMed ID: 17892998
[TBL] [Abstract][Full Text] [Related]
5. Effects of the PPARG P12A and C161T gene variants on serum lipids in coronary heart disease patients with and without Type 2 diabetes.
Yilmaz-Aydogan H; Kurnaz O; Kurt O; Akadam-Teker B; Kucukhuseyin O; Tekeli A; Isbir T
Mol Cell Biochem; 2011 Dec; 358(1-2):355-63. PubMed ID: 21833536
[TBL] [Abstract][Full Text] [Related]
6. Peroxisome proliferator-activated receptor gamma C161-->T polymorphism and coronary artery disease.
Wang XL; Oosterhof J; Duarte N
Cardiovasc Res; 1999 Dec; 44(3):588-94. PubMed ID: 10690291
[TBL] [Abstract][Full Text] [Related]
7. rs10865710 polymorphism in PPARG promoter is associated with the severity of type 2 diabetes mellitus and coronary artery disease in a Chinese population.
Song Y; Raheel TM; Jia A; Dai G; Liu L; Long X; He C
Postgrad Med J; 2022 Oct; 98(1164):778-787. PubMed ID: 37062988
[TBL] [Abstract][Full Text] [Related]
8. Association between Pro12Ala polymorphism of the PPAR-gamma2 gene and insulin sensitivity in Brazilian patients with type-2 diabetes mellitus.
Tavares V; Hirata RD; Rodrigues AC; Monte O; Salles JE; Scalissi N; Speranza AC; Hirata MH
Diabetes Obes Metab; 2005 Sep; 7(5):605-11. PubMed ID: 16050954
[TBL] [Abstract][Full Text] [Related]
9. Apolipoprotein E gene polymorphism: effects on plasma lipids and risk of type 2 diabetes and coronary artery disease.
Chaudhary R; Likidlilid A; Peerapatdit T; Tresukosol D; Srisuma S; Ratanamaneechat S; Sriratanasathavorn C
Cardiovasc Diabetol; 2012 Apr; 11():36. PubMed ID: 22520940
[TBL] [Abstract][Full Text] [Related]
10. Association of peroxisome proliferator-activated receptorgamma gene Pro12Ala and C161T polymorphisms with metabolic syndrome.
Dongxia L; Qi H; Lisong L; Jincheng G
Circ J; 2008 Apr; 72(4):551-7. PubMed ID: 18362424
[TBL] [Abstract][Full Text] [Related]
11. Impact of the C1431T Polymorphism of the Peroxisome Proliferator Activated Receptor-Gamma (PPAR-γ) Gene on Fasted Serum Lipid Levels in Patients with Coronary Artery Disease.
Oladi M; Nohtani M; Avan A; Mirhafez SR; Tajbakhsh A; Ghasemi F; Asadi A; Elahdadi Salmani M; Mohammadi A; Hoseinzadeh L; Ferns GA; Ghayour Mobarhan M
Ann Nutr Metab; 2015; 66(2-3):149-154. PubMed ID: 25896411
[TBL] [Abstract][Full Text] [Related]
12. Postprandial metabolism of apolipoprotein B-48- and B-100-containing particles in type 2 diabetes mellitus: relations to angiographically verified severity of coronary artery disease.
Mero N; Malmström R; Steiner G; Taskinen MR; Syvänne M
Atherosclerosis; 2000 May; 150(1):167-77. PubMed ID: 10781648
[TBL] [Abstract][Full Text] [Related]
13. A Pro 12 Ala substitution in the PPARγ2 polymorphism may decrease the number of diseased vessels and the severity of angiographic coronary artery.
Youssef SM; Mohamed N; Afef S; Khaldoun BH; Fadoua N; Fadhel NM; Naceur SM
Coron Artery Dis; 2013 Aug; 24(5):347-51. PubMed ID: 23652363
[TBL] [Abstract][Full Text] [Related]
14. The gene polymorphisms of UCP1 but not PPAR γ and TCF7L2 are associated with diabetic retinopathy in Chinese type 2 diabetes mellitus cases.
Zhang Y; Meng N; Lv Z; Li H; Qu Y
Acta Ophthalmol; 2015 May; 93(3):e223-9. PubMed ID: 25274455
[TBL] [Abstract][Full Text] [Related]
15. Different effects of PPARA, PPARG and ApoE SNPs on serum lipids in patients with coronary heart disease based on the presence of diabetes.
Yilmaz-Aydogan H; Kurnaz O; Kucukhuseyin O; Akadam-Teker B; Kurt O; Eronat AP; Tekeli A; Bugra Z; Ozturk O
Gene; 2013 Jul; 523(1):20-6. PubMed ID: 23583468
[TBL] [Abstract][Full Text] [Related]
16. [Peroxisome proliferator-activated receptor gamma C-161T polymorphism and carotid artery atherosclerosis in metabolic syndrome].
Yan ZC; Zhu ZM; Shen CY; Zhao ZG; Ni YX; Zhong J; Nie H
Zhonghua Yi Xue Za Zhi; 2004 Apr; 84(7):543-7. PubMed ID: 15144586
[TBL] [Abstract][Full Text] [Related]
17. Genetic polymorphisms in peroxisome proliferator-activated receptor gamma are associated with Type 2 diabetes mellitus and obesity in the Korean population.
Moon MK; Cho YM; Jung HS; Park YJ; Yoon KH; Sung YA; Park BL; Lee HK; Park KS; Shin HD
Diabet Med; 2005 Sep; 22(9):1161-6. PubMed ID: 16108843
[TBL] [Abstract][Full Text] [Related]
18. The presence of apolipoprotein epsilon4 and epsilon2 alleles augments the risk of coronary artery disease in type 2 diabetic patients.
Vaisi-Raygani A; Rahimi Z; Nomani H; Tavilani H; Pourmotabbed T
Clin Biochem; 2007 Oct; 40(15):1150-6. PubMed ID: 17689519
[TBL] [Abstract][Full Text] [Related]
19. Peroxisome proliferator-activated receptor gamma gene polymorphism is associated with serum triglyceride levels and body mass index in Japanese type 2 diabetic patients.
Maeda A; Gohda T; Funabiki K; Horikoshi S; Tomino Y
J Clin Lab Anal; 2004; 18(6):317-21. PubMed ID: 15543562
[TBL] [Abstract][Full Text] [Related]
20. PPARγ Pro12Ala and C161T polymorphisms in patients with acne vulgaris: Contribution to lipid and lipoprotein profile.
Saeidi S; Chamaie-Nejad F; Ebrahimi A; Najafi F; Rahimi Z; Vaisi-Raygani A; Shakiba E; Rahimi Z
Adv Med Sci; 2018 Mar; 63(1):147-151. PubMed ID: 29120856
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
